Twin Capital Management Inc. Has $2.22 Million Stake in Cardinal Health, Inc. (CAH)
Twin Capital Management Inc. boosted its position in Cardinal Health, Inc. (NYSE:CAH) by 133.2% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 28,432 shares of the company’s stock after buying an additional 16,242 shares during the period. Twin Capital Management Inc.’s holdings in Cardinal Health were worth $2,215,000 as of its most recent SEC filing.
Several other hedge funds have also recently bought and sold shares of the company. Advisory Services Network LLC purchased a new stake in Cardinal Health during the first quarter worth $120,000. JFS Wealth Advisors LLC raised its stake in Cardinal Health by 14.3% in the second quarter. JFS Wealth Advisors LLC now owns 1,949 shares of the company’s stock worth $152,000 after buying an additional 244 shares in the last quarter. Dupont Capital Management Corp purchased a new stake in Cardinal Health during the second quarter worth $164,000. First Personal Financial Services raised its stake in Cardinal Health by 127.5% in the second quarter. First Personal Financial Services now owns 2,209 shares of the company’s stock worth $172,000 after buying an additional 1,238 shares in the last quarter. Finally, Alpha Windward LLC raised its stake in Cardinal Health by 0.7% in the second quarter. Alpha Windward LLC now owns 2,299 shares of the company’s stock worth $179,000 after buying an additional 17 shares in the last quarter. Institutional investors own 86.41% of the company’s stock.
Cardinal Health, Inc. (NYSE:CAH) opened at 66.08 on Friday. Cardinal Health, Inc. has a 52 week low of $62.70 and a 52 week high of $84.88. The company has a market cap of $20.91 billion, a P/E ratio of 16.40 and a beta of 0.80. The firm’s 50 day moving average is $72.15 and its 200-day moving average is $76.23.
Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Wednesday, August 2nd. The company reported $1.31 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.24 by $0.07. Cardinal Health had a net margin of 0.99% and a return on equity of 26.20%. The business had revenue of $32.97 billion during the quarter, compared to analyst estimates of $32.73 billion. During the same quarter last year, the firm posted $1.14 earnings per share. The business’s revenue for the quarter was up 5.0% compared to the same quarter last year. On average, analysts predict that Cardinal Health, Inc. will post $4.96 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Sunday, October 15th. Stockholders of record on Monday, October 2nd will be paid a $0.4624 dividend. This represents a $1.85 annualized dividend and a dividend yield of 2.80%. The ex-dividend date of this dividend is Friday, September 29th. Cardinal Health’s payout ratio is 45.79%.
TRADEMARK VIOLATION WARNING: “Twin Capital Management Inc. Has $2.22 Million Stake in Cardinal Health, Inc. (CAH)” was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this article on another publication, it was stolen and republished in violation of US and international trademark and copyright laws. The correct version of this article can be viewed at https://www.thecerbatgem.com/2017/08/26/twin-capital-management-inc-has-2-22-million-stake-in-cardinal-health-inc-cah.html.
A number of research firms have recently weighed in on CAH. UBS AG reiterated a “neutral” rating and set a $76.00 target price (down from $79.00) on shares of Cardinal Health in a report on Thursday, August 3rd. Credit Suisse Group reiterated an “outperform” rating and set a $87.00 target price (up from $81.00) on shares of Cardinal Health in a report on Thursday, July 13th. BidaskClub lowered shares of Cardinal Health from a “buy” rating to a “hold” rating in a report on Monday, July 24th. Jefferies Group LLC started coverage on shares of Cardinal Health in a research note on Wednesday, May 17th. They issued a “hold” rating and a $77.00 price target for the company. Finally, Zacks Investment Research downgraded shares of Cardinal Health from a “hold” rating to a “sell” rating in a research note on Monday, August 7th. Two equities research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and four have assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $80.46.
Cardinal Health Company Profile
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Receive News & Stock Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related stocks with our FREE daily email newsletter.